Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function

Yong Ji, M. Jane Lalli, Gopal J. Babu, Yanfang Xu, Darryl L. Kirkpatrick, Lynne H. Liu, Nipavan Chiamvimonvat, Richard A. Walsh, Gary E. Shull, Muthu Periasamy

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

A mouse model carrying a null mutation in one copy of the sarcoplasmic reticulum (SR) Ca2+-ATPase isoform 2 (SERCA2) gene, in which SERCA2 protein levels are reduced by ~35%, was used to investigate the effects of decreased SERCA2 level on intracellular Ca2+ homeostasis and contractile properties in isolated cardiomyocytes. When compared with wild-type controls, SR Ca2+ stores and Ca2+ release in myocytes of SERCA2 heterozygous mice were decreased by ~40-60% and ~30-40%, respectively, and the rate of myocyte shortening and relengthening were each decreased by ~40%. However, the rate of Ca2+ transient decline (τ) was not altered significantly, suggesting that compensation was occurring in the removal of Ca2+ from the cytosol. Phospholamban, which inhibits SERCA2, was decreased by ~40% in heterozygous hearts, and basal phosphorylation of Ser-16 and Thr-17, which relieves the inhibition, was increased ~2- and 2.1-fold. These results indicate that reduced expression and increased phosphorylatlon of phospholamban provides compensation for decreased SERCA2 protein levels in heterozygous heart. Furthermore, both expression and current density of the sarcolemmal Na+-Ca2+ exchanger were up-regulated. These results demonstrate that a decrease in SERCA2 levels can directly modify intracellular Ca2+ homeostasis and myocyte contractility. However, the resulting deficit is partially compensated by alterations in phospholamban/SERCA2 interactions and by up-regulation of the Na+-Ca2+ exchanger.

Original languageEnglish (US)
Pages (from-to)38073-38080
Number of pages8
JournalJournal of Biological Chemistry
Volume275
Issue number48
DOIs
StatePublished - Dec 1 2000
Externally publishedYes

Fingerprint

Cardiac Myocytes
Muscle Cells
Homeostasis
Genes
Sarcoplasmic Reticulum
Phosphorylation
Calcium-Transporting ATPases
Cytosol
Protein Isoforms
Proteins
Current density
Up-Regulation
Mutation
phospholamban
Compensation and Redress

ASJC Scopus subject areas

  • Biochemistry

Cite this

Ji, Y., Lalli, M. J., Babu, G. J., Xu, Y., Kirkpatrick, D. L., Liu, L. H., ... Periasamy, M. (2000). Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. Journal of Biological Chemistry, 275(48), 38073-38080. https://doi.org/10.1074/jbc.M004804200

Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. / Ji, Yong; Lalli, M. Jane; Babu, Gopal J.; Xu, Yanfang; Kirkpatrick, Darryl L.; Liu, Lynne H.; Chiamvimonvat, Nipavan; Walsh, Richard A.; Shull, Gary E.; Periasamy, Muthu.

In: Journal of Biological Chemistry, Vol. 275, No. 48, 01.12.2000, p. 38073-38080.

Research output: Contribution to journalArticle

Ji, Y, Lalli, MJ, Babu, GJ, Xu, Y, Kirkpatrick, DL, Liu, LH, Chiamvimonvat, N, Walsh, RA, Shull, GE & Periasamy, M 2000, 'Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function', Journal of Biological Chemistry, vol. 275, no. 48, pp. 38073-38080. https://doi.org/10.1074/jbc.M004804200
Ji, Yong ; Lalli, M. Jane ; Babu, Gopal J. ; Xu, Yanfang ; Kirkpatrick, Darryl L. ; Liu, Lynne H. ; Chiamvimonvat, Nipavan ; Walsh, Richard A. ; Shull, Gary E. ; Periasamy, Muthu. / Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 48. pp. 38073-38080.
@article{401d375fae464295b29777b82d82cb86,
title = "Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function",
abstract = "A mouse model carrying a null mutation in one copy of the sarcoplasmic reticulum (SR) Ca2+-ATPase isoform 2 (SERCA2) gene, in which SERCA2 protein levels are reduced by ~35{\%}, was used to investigate the effects of decreased SERCA2 level on intracellular Ca2+ homeostasis and contractile properties in isolated cardiomyocytes. When compared with wild-type controls, SR Ca2+ stores and Ca2+ release in myocytes of SERCA2 heterozygous mice were decreased by ~40-60{\%} and ~30-40{\%}, respectively, and the rate of myocyte shortening and relengthening were each decreased by ~40{\%}. However, the rate of Ca2+ transient decline (τ) was not altered significantly, suggesting that compensation was occurring in the removal of Ca2+ from the cytosol. Phospholamban, which inhibits SERCA2, was decreased by ~40{\%} in heterozygous hearts, and basal phosphorylation of Ser-16 and Thr-17, which relieves the inhibition, was increased ~2- and 2.1-fold. These results indicate that reduced expression and increased phosphorylatlon of phospholamban provides compensation for decreased SERCA2 protein levels in heterozygous heart. Furthermore, both expression and current density of the sarcolemmal Na+-Ca2+ exchanger were up-regulated. These results demonstrate that a decrease in SERCA2 levels can directly modify intracellular Ca2+ homeostasis and myocyte contractility. However, the resulting deficit is partially compensated by alterations in phospholamban/SERCA2 interactions and by up-regulation of the Na+-Ca2+ exchanger.",
author = "Yong Ji and Lalli, {M. Jane} and Babu, {Gopal J.} and Yanfang Xu and Kirkpatrick, {Darryl L.} and Liu, {Lynne H.} and Nipavan Chiamvimonvat and Walsh, {Richard A.} and Shull, {Gary E.} and Muthu Periasamy",
year = "2000",
month = "12",
day = "1",
doi = "10.1074/jbc.M004804200",
language = "English (US)",
volume = "275",
pages = "38073--38080",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "48",

}

TY - JOUR

T1 - Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function

AU - Ji, Yong

AU - Lalli, M. Jane

AU - Babu, Gopal J.

AU - Xu, Yanfang

AU - Kirkpatrick, Darryl L.

AU - Liu, Lynne H.

AU - Chiamvimonvat, Nipavan

AU - Walsh, Richard A.

AU - Shull, Gary E.

AU - Periasamy, Muthu

PY - 2000/12/1

Y1 - 2000/12/1

N2 - A mouse model carrying a null mutation in one copy of the sarcoplasmic reticulum (SR) Ca2+-ATPase isoform 2 (SERCA2) gene, in which SERCA2 protein levels are reduced by ~35%, was used to investigate the effects of decreased SERCA2 level on intracellular Ca2+ homeostasis and contractile properties in isolated cardiomyocytes. When compared with wild-type controls, SR Ca2+ stores and Ca2+ release in myocytes of SERCA2 heterozygous mice were decreased by ~40-60% and ~30-40%, respectively, and the rate of myocyte shortening and relengthening were each decreased by ~40%. However, the rate of Ca2+ transient decline (τ) was not altered significantly, suggesting that compensation was occurring in the removal of Ca2+ from the cytosol. Phospholamban, which inhibits SERCA2, was decreased by ~40% in heterozygous hearts, and basal phosphorylation of Ser-16 and Thr-17, which relieves the inhibition, was increased ~2- and 2.1-fold. These results indicate that reduced expression and increased phosphorylatlon of phospholamban provides compensation for decreased SERCA2 protein levels in heterozygous heart. Furthermore, both expression and current density of the sarcolemmal Na+-Ca2+ exchanger were up-regulated. These results demonstrate that a decrease in SERCA2 levels can directly modify intracellular Ca2+ homeostasis and myocyte contractility. However, the resulting deficit is partially compensated by alterations in phospholamban/SERCA2 interactions and by up-regulation of the Na+-Ca2+ exchanger.

AB - A mouse model carrying a null mutation in one copy of the sarcoplasmic reticulum (SR) Ca2+-ATPase isoform 2 (SERCA2) gene, in which SERCA2 protein levels are reduced by ~35%, was used to investigate the effects of decreased SERCA2 level on intracellular Ca2+ homeostasis and contractile properties in isolated cardiomyocytes. When compared with wild-type controls, SR Ca2+ stores and Ca2+ release in myocytes of SERCA2 heterozygous mice were decreased by ~40-60% and ~30-40%, respectively, and the rate of myocyte shortening and relengthening were each decreased by ~40%. However, the rate of Ca2+ transient decline (τ) was not altered significantly, suggesting that compensation was occurring in the removal of Ca2+ from the cytosol. Phospholamban, which inhibits SERCA2, was decreased by ~40% in heterozygous hearts, and basal phosphorylation of Ser-16 and Thr-17, which relieves the inhibition, was increased ~2- and 2.1-fold. These results indicate that reduced expression and increased phosphorylatlon of phospholamban provides compensation for decreased SERCA2 protein levels in heterozygous heart. Furthermore, both expression and current density of the sarcolemmal Na+-Ca2+ exchanger were up-regulated. These results demonstrate that a decrease in SERCA2 levels can directly modify intracellular Ca2+ homeostasis and myocyte contractility. However, the resulting deficit is partially compensated by alterations in phospholamban/SERCA2 interactions and by up-regulation of the Na+-Ca2+ exchanger.

UR - http://www.scopus.com/inward/record.url?scp=0034537410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034537410&partnerID=8YFLogxK

U2 - 10.1074/jbc.M004804200

DO - 10.1074/jbc.M004804200

M3 - Article

C2 - 10970890

AN - SCOPUS:0034537410

VL - 275

SP - 38073

EP - 38080

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 48

ER -